{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:14:37Z","timestamp":1790799277666,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T00:00:00Z","timestamp":1716595200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T00:00:00Z","timestamp":1716595200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81770537"],"award-info":[{"award-number":["81770537"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070554"],"award-info":[{"award-number":["82070554"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Major Scientific and Technological Special Project for Public Health in Tianjin","award":["21ZXGWSY00080"],"award-info":[{"award-number":["21ZXGWSY00080"]}]},{"name":"Tianjin Medical University General Hospital Clincal Research Program","award":["22ZYYLCCG06"],"award-info":[{"award-number":["22ZYYLCCG06"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Updates Surg"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s13304-024-01814-6","type":"journal-article","created":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T09:01:22Z","timestamp":1716627682000},"page":"1223-1234","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Construction and validation of nomogram prognostic model for predicting survival in hepatoblastoma patients: a population-based study"],"prefix":"10.1007","volume":"76","author":[{"given":"Song","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqi","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daqing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,25]]},"reference":[{"key":"1814_CR1","doi-asserted-by":"publisher","first-page":"79","DOI":"10.24095\/hpcdp.38.3.01","volume":"38","author":"L Xie","year":"2018","unstructured":"Xie L, Onysko J, Morrison H (2018) Childhood cancer incidence in Canada: demographic and geographic variation of temporal trends (1992\u20132010). Health Promot Chronic Dis Prev Can 38:79\u2013115. https:\/\/doi.org\/10.24095\/hpcdp.38.3.01","journal-title":"Health Promot Chronic Dis Prev Can"},{"key":"1814_CR2","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1111\/hpb.12112","volume":"15","author":"BJ Allan","year":"2013","unstructured":"Allan BJ, Parikh PP, Diaz S, Perez EA, Neville HL, Sola JE (2013) Predictors of survival and incidence of hepatoblastoma in the paediatric population. HPB (Oxford) 15:741\u2013746. https:\/\/doi.org\/10.1111\/hpb.12112","journal-title":"HPB (Oxford)"},{"key":"1814_CR3","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1177\/1093526619875228","volume":"23","author":"S Ranganathan","year":"2020","unstructured":"Ranganathan S, Lopez-Terrada D, Alaggio R (2020) Hepatoblastoma and pediatric hepatocellular carcinoma: an update. Pediatr Dev Pathol 23:79\u201395. https:\/\/doi.org\/10.1177\/1093526619875228","journal-title":"Pediatr Dev Pathol"},{"key":"1814_CR4","doi-asserted-by":"publisher","first-page":"555","DOI":"10.21037\/atm.2019.09.76","volume":"7","author":"TC Feng","year":"2019","unstructured":"Feng TC, Zai HY, Jiang W, Zhu Q, Jiang B, Yao L et al (2019) Survival and analysis of prognostic factors for hepatoblastoma: based on SEER database. Ann Transl Med 7:555. https:\/\/doi.org\/10.21037\/atm.2019.09.76","journal-title":"Ann Transl Med"},{"key":"1814_CR5","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1002\/pbc.24215","volume":"59","author":"LG Spector","year":"2012","unstructured":"Spector LG, Birch J (2012) The epidemiology of hepatoblastoma. Pediatr Blood Cancer 59:776\u2013779. https:\/\/doi.org\/10.1002\/pbc.24215","journal-title":"Pediatr Blood Cancer"},{"key":"1814_CR6","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/0022-3468(75)90095-0","volume":"10","author":"PR Exelby","year":"1975","unstructured":"Exelby PR, Filler RM, Grosfeld JL (1975) Liver tumors in children in the particular reference to hepatoblastoma and hepatocellular carcinoma: American Academy of Pediatrics Surgical Section Survey\u20131974. J Pediatr Surg 10:329\u2013337. https:\/\/doi.org\/10.1016\/0022-3468(75)90095-0","journal-title":"J Pediatr Surg"},{"key":"1814_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.sempedsurg.2019.150856","volume":"28","author":"CM Lake","year":"2019","unstructured":"Lake CM, Tiao GM, Bondoc AJ (2019) Surgical management of locally-advanced and metastatic hepatoblastoma. Semin Pediatr Surg 28:150856. https:\/\/doi.org\/10.1016\/j.sempedsurg.2019.150856","journal-title":"Semin Pediatr Surg"},{"key":"1814_CR8","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/bjs.9681","volume":"102","author":"R Venkatramani","year":"2015","unstructured":"Venkatramani R, Stein JE, Sapra A, Genyk Y, Jhaveri V, Malogolowkin M et al (2015) Effect of neoadjuvant chemotherapy on resectability of stage III and IV hepatoblastoma. Br J Surg 102:108\u2013113. https:\/\/doi.org\/10.1002\/bjs.9681","journal-title":"Br J Surg"},{"key":"1814_CR9","doi-asserted-by":"publisher","first-page":"221","DOI":"10.2165\/11597740-000000000-00000","volume":"14","author":"R Venkatramani","year":"2012","unstructured":"Venkatramani R, Furman WL, Fuchs J, Warmann SW, Malogolowkin MH (2012) Current and future management strategies for relapsed or progressive hepatoblastoma. Paediatr Drugs 14:221\u2013232. https:\/\/doi.org\/10.2165\/11597740-000000000-00000","journal-title":"Paediatr Drugs"},{"key":"1814_CR10","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.ejca.2005.02.004","volume":"41","author":"P Czauderna","year":"2005","unstructured":"Czauderna P, Otte JB, Aronson DC, Gauthier F, Mackinlay G, Roebuck D et al (2005) Guidelines for surgical treatment of hepatoblastoma in the modern era\u2013recommendations from the Childhood Liver Tumour Strategy Group of the International Society of Paediatric Oncology (SIOPEL). Eur J Cancer 41:1031\u20131036. https:\/\/doi.org\/10.1016\/j.ejca.2005.02.004","journal-title":"Eur J Cancer"},{"key":"1814_CR11","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/s1470-2045(16)30598-8","volume":"18","author":"RL Meyers","year":"2017","unstructured":"Meyers RL, Maibach R, Hiyama E, H\u00e4berle B, Krailo M, Rangaswami A et al (2017) Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children\u2019s Hepatic tumors International Collaboration. Lancet Oncol 18:122\u2013131. https:\/\/doi.org\/10.1016\/s1470-2045(16)30598-8","journal-title":"Lancet Oncol"},{"key":"1814_CR12","doi-asserted-by":"publisher","first-page":"201","DOI":"10.4103\/0971-9261.142001","volume":"19","author":"DC Aronson","year":"2014","unstructured":"Aronson DC, Czauderna P, Maibach R, Perilongo G, Morland B (2014) The treatment of hepatoblastoma: Its evolution and the current status as per the SIOPEL trials. J Indian Assoc Pediatr Surg 19:201\u2013207. https:\/\/doi.org\/10.4103\/0971-9261.142001","journal-title":"J Indian Assoc Pediatr Surg"},{"key":"1814_CR13","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1634\/theoncologist.8-6-541","volume":"8","author":"LA Gloeckler Ries","year":"2003","unstructured":"Gloeckler Ries LA, Reichman ME, Lewis DR, Hankey BF, Edwards BK (2003) Cancer survival and incidence from the Surveillance, Epidemiology, and End Results (SEER) program. Oncologist 8:541\u2013552. https:\/\/doi.org\/10.1634\/theoncologist.8-6-541","journal-title":"Oncologist"},{"key":"1814_CR14","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g7594","volume":"350","author":"GS Collins","year":"2015","unstructured":"Collins GS, Reitsma JB, Altman DG, Moons KG (2015) Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. BMJ 350:g7594. https:\/\/doi.org\/10.1136\/bmj.g7594","journal-title":"BMJ"},{"key":"1814_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.29763","volume":"69","author":"JA Kahla","year":"2022","unstructured":"Kahla JA, Siegel DA, Dai S, Lupo PJ, Foster JH, Scheurer ME et al (2022) Incidence and 5-year survival of children and adolescents with hepatoblastoma in the United States. Pediatr Blood Cancer 69:e29763. https:\/\/doi.org\/10.1002\/pbc.29763","journal-title":"Pediatr Blood Cancer"},{"key":"1814_CR16","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ijscr.2016.02.019","volume":"21","author":"A El Asmar","year":"2016","unstructured":"El Asmar A, El Rassi Z (2016) Hepatoblastoma in childhood, long term survival achieved: 2 case reports and literature review. Int J Surg Case Rep 21:55\u201358. https:\/\/doi.org\/10.1016\/j.ijscr.2016.02.019","journal-title":"Int J Surg Case Rep"},{"key":"1814_CR17","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1016\/s0959-8049(00)00074-5","volume":"36","author":"J Brown","year":"2000","unstructured":"Brown J, Perilongo G, Shafford E, Keeling J, Pritchard J, Brock P et al (2000) Pretreatment prognostic factors for children with hepatoblastoma\u2013 results from the International Society of Paediatric Oncology (SIOP) study SIOPEL 1. Eur J Cancer 36:1418\u20131425. https:\/\/doi.org\/10.1016\/s0959-8049(00)00074-5","journal-title":"Eur J Cancer"},{"key":"1814_CR18","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1053\/j.sempedsurg.2011.10.011","volume":"21","author":"D von Schweinitz","year":"2012","unstructured":"von Schweinitz D (2012) Hepatoblastoma: recent developments in research and treatment. Semin Pediatr Surg 21:21\u201330. https:\/\/doi.org\/10.1053\/j.sempedsurg.2011.10.011","journal-title":"Semin Pediatr Surg"},{"key":"1814_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2003.06.003","author":"G Perilongo","year":"2004","unstructured":"Perilongo G, Shafford E, Maibach R, Aronson D, Brugi\u00e8res L, Brock P et al (2004) Risk-adapted treatment for childhood hepatoblastoma final report of the second study of the International Society of Paediatric Oncology\u2013SIOPEL 2. Eur J Cancer. https:\/\/doi.org\/10.1016\/j.ejca.2003.06.003","journal-title":"Eur J Cancer."},{"key":"1814_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11091387","author":"HM Yoon","year":"2019","unstructured":"Yoon HM, Hwang J, Kim KW, Namgoong JM, Kim DY, Koh KN et al (2019) Prognostic factors for event-free survival in pediatric patients with hepatoblastoma based on the 2017 PRETEXT and CHIC-HS systems. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers11091387","journal-title":"Cancers (Basel)"},{"key":"1814_CR21","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s12887-021-02630-2","volume":"21","author":"T Zhi","year":"2021","unstructured":"Zhi T, Zhang WL, Zhang Y, Hu HM, Huang DS (2021) Clinical characteristics and prognostic factors of hepatoblastoma in 316 children aged under 3 years - a 14-year retrospective single-center study. BMC Pediatr 21:170. https:\/\/doi.org\/10.1186\/s12887-021-02630-2","journal-title":"BMC Pediatr"},{"key":"1814_CR22","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1002\/cncr.30591","volume":"123","author":"HM Katzenstein","year":"2017","unstructured":"Katzenstein HM, Furman WL, Malogolowkin MH, Krailo MD, McCarville MB, Towbin AJ et al (2017) Upfront window vincristine\/irinotecan treatment of high-risk hepatoblastoma: a report from the Children\u2019s Oncology Group AHEP0731 study committee. Cancer 123:2360\u20132367. https:\/\/doi.org\/10.1002\/cncr.30591","journal-title":"Cancer"},{"key":"1814_CR23","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1002\/lt.21586","volume":"14","author":"W Faraj","year":"2008","unstructured":"Faraj W, Dar F, Marangoni G, Bartlett A, Melendez HV, Hadzic D et al (2008) Liver transplantation for hepatoblastoma. Liver Transpl 14:1614\u20131619. https:\/\/doi.org\/10.1002\/lt.21586","journal-title":"Liver Transpl"},{"key":"1814_CR24","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.jpedsurg.2022.02.024","volume":"57","author":"M Ke","year":"2022","unstructured":"Ke M, Zhou Y, Yang CZ, Li L, Diao M (2022) Analysis of risk factors for angiolymphatic invasion and establishment of a predictive nomogram for hepatoblastomas. J Pediatr Surg 57:430\u2013437. https:\/\/doi.org\/10.1016\/j.jpedsurg.2022.02.024","journal-title":"J Pediatr Surg"},{"key":"1814_CR25","doi-asserted-by":"publisher","DOI":"10.1111\/petr.13268","volume":"22","author":"SJ Shi","year":"2018","unstructured":"Shi SJ, Wang DL, Hu W, Peng F, Kang Q (2018) Ex vivo liver resection and autotransplantation with cardiopulmonary bypass for hepatoblastoma in children: a case report. Pediatr Transplant 22:e13268. https:\/\/doi.org\/10.1111\/petr.13268","journal-title":"Pediatr Transplant"},{"key":"1814_CR26","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.jcma.2017.11.012","volume":"81","author":"GY Hung","year":"2018","unstructured":"Hung GY, Lin LY, Yu TY, Lee CY, Yen HJ, Horng JL (2018) Hepatoblastoma incidence in Taiwan: a population-based study. J Chin Med Assoc 81:541\u2013547. https:\/\/doi.org\/10.1016\/j.jcma.2017.11.012","journal-title":"J Chin Med Assoc"},{"key":"1814_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.29932","author":"M Ke","year":"2022","unstructured":"Ke M, Zhou Y, Chang-Zhen Y, Li L, Diao M (2022) A nomogram model to predict prognosis of patients with hepatoblastoma. Pediatr Blood Cancer. https:\/\/doi.org\/10.1002\/pbc.29932","journal-title":"Pediatr Blood Cancer."}],"container-title":["Updates in Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13304-024-01814-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13304-024-01814-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13304-024-01814-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T17:16:46Z","timestamp":1724433406000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13304-024-01814-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,25]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["1814"],"URL":"https:\/\/doi.org\/10.1007\/s13304-024-01814-6","relation":{},"ISSN":["2038-131X","2038-3312"],"issn-type":[{"value":"2038-131X","type":"print"},{"value":"2038-3312","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,25]]},"assertion":[{"value":"24 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study contained in this manuscript has no human participants, which waives the need for ethics approval and written informed consent from participants to take part in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics statement"}}]}}